The Dopamine Transporter is Decreased in the Striatum of Subjects with Restless Legs Syndrome
Open Access
- 1 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 34 (3) , 341-347
Abstract
Prior studies, all using SPECT techniques, failed to find any differences for dopamine transporter (DAT) in restless legs syndrome (RLS) subjects. The distinct pharmacokinetic properties associated with SPECT-determined DAT along with rapid biodynamic changes in DAT may, however, have missed membrane-bound DAT differences. The current studies assessed real-time DAT binding potentials (BP) in striatum of RLS patients using 11C-methylphenidate and PET techniques. RLS medications were stopped at least 11 days prior to the PET study. Clinical severity of RLS was also assessed. PET scans were performed at 2 different times of day (starting at 08:30 and 19:30) in separate groups of subjects. The primary outcome measure was total striatal DAT BP. Thirty-six patients with primary RLS and 34 age- and gender-matched controls. RLS subjects had significantly lower DAT binding in the striatum compared to controls on both the Day and the Night scans. DAT was decreased in putamen and caudate but not the ventral striatum of RLS subjects. There were no diurnal differences in DAT for the total group or for control and RLS separately. DAT BP did not correlate with any clinical measures of RLS. The current study found a significant decrease in DAT BP in two independent studies. These results when viewed along with prior RLS SPECT and autopsy studies of DAT, and cell culture studies with iron deficiency and DAT, suggest that membrane-bound striatal DAT, but not total cellular DAT, may be decreased in RLS.Keywords
This publication has 43 references indexed in Scilit:
- The dopaminergic neurons of the A11 system in RLS autopsy brains appear normalSleep Medicine, 2009
- Visualization of Dopamine Transporter Trafficking in Live Neurons by Use of Fluorescent Cocaine AnalogsJournal of Neuroscience, 2009
- Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndromeBrain, 2009
- Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairmentNeuroImage, 2009
- A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndromeSleep Medicine, 2009
- Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesisSleep Medicine, 2009
- Sleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3Receptors in the Human BrainThe Journal of Neuroscience, 2008
- Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndromeJournal of Neural Transmission, 2004
- Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patientsMovement Disorders, 2003
- Comparison of two PET radioligands for imaging extrastriatal dopamine transporters in human brainLife Sciences, 1995